Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease

Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study

(2016) Paul Valensi et al.   Cardiovascular Diabetology

Beyond Coronary Calcification, Family History, and C-Reactive Protein

(2016) Purav Mody et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

(2016) Paolo Zanoni et al.   SCIENCE

Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study

(2016) Wijtske Annema et al.   Scientific Reports

Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol

(2015) Olga V. Savinova et al.   ATHEROSCLEROSIS

Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT

(2015) Diego Lucero et al.   ATHEROSCLEROSIS

Kinetic and Thermodynamic Analyses of Spontaneous Exchange between High-Density Lipoprotein-Bound and Lipid-Free Apolipoprotein A-I

(2015) Daisuke Handa et al.   BIOCHEMISTRY

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia

(2015) Peter J. Meikle et al.   JOURNAL OF LIPID RESEARCH

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity

(2015) Mark S. Borja et al.   JOURNAL OF LIPID RESEARCH

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

(2015) Danish Saleheen et al.   Lancet Diabetes & Endocrinology

Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase

(2014) Baohai Shao et al.   CIRCULATION RESEARCH

Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes

(2014) Hussein N. Yassine et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

(2014) Anand Rohatgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reduced Apolipoprotein Glycosylation in Patients with the Metabolic Syndrome

(2014) Olga V. Savinova et al.   PLoS One

Importance of Evaluating Cell Cholesterol Influx With Efflux in Determining the Impact of Human Serum on Cholesterol Metabolism and Atherosclerosis

(2013) Ginny L. Weibel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis

(2013) Mark S. Borja et al.   PLoS One

Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial

(2012) Gregory C. Shearer et al.   JOURNAL OF LIPID RESEARCH

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

(2012) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL

(2011) Baohai Shao   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Metabolic and functional relevance of HDL subspecies

(2011) Bela F Asztalos et al.   CURRENT OPINION IN LIPIDOLOGY

Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects

(2011) P Nestel et al.   INTERNATIONAL JOURNAL OF OBESITY

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

(2010) Margarita de la Llera-Moya et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High Pre- 1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol

(2010) A. A. Sethi et al.   CLINICAL CHEMISTRY

Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export

(2010) Baohai Shao et al.   JOURNAL OF LIPID RESEARCH

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

(2008) Jean-Charles Fruchart et al.   Diabetes & Vascular Disease Research

Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol

(2008) Robin P F Dullaart et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

(2008) Michael Miller et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

(2007) Juliana A. de Souza et al.   ATHEROSCLEROSIS

Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification

(2007) R. de Vries et al.   ATHEROSCLEROSIS